BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/13/2021 1:00:01 PM | Browse: 29 | Download: 71
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 66172
Country/Territory China
2021-03-22 06:18
Peer-Review Started
2021-03-22 06:22
To Make the First Decision
Return for Revision
2021-06-14 03:48
2021-06-28 07:08
Second Decision
2021-08-12 03:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-08-12 08:43
Articles in Press
2021-08-12 08:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-08-31 02:46
Typeset the Manuscript
2021-10-08 16:23
Publish the Manuscript Online
2021-10-13 12:57
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Frontier
Article Title Engineering nanotheranostic strategies for liver cancer
Manuscript Source Invited Manuscript
All Author List Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang and Hong-Wei Cheng
Funding Agency and Grant Number
Funding Agency Grant Number
Science and Technology Innovation Joint Fund Project of Fujian Province 2019Y9044
Science and Technology Project of Quanzhou 2018Z155
Corresponding Author Hong-Wei Cheng, MD, Research Associate, School of Public Health, Xiamen University, Xiangan South Road, Xiangan District, Xiamen 361002, Fujian Province, China. hongwei1026@hotmail.com
Key Words Liver cancer; Poor prognosis; Nanotheranostic; Drug delivery; Gene delivery; Combination therapy
Core Tip With the development of nanotheranostic strategies in liver cancer treatment, the efficacy of drug delivery is improved by smart nanoparticles with excellent targeting capacity. To overcome the complex tumor microenvironment, the nanosystems with combined strategies of curative or palliative treatments show the significant synergistic therapeutic effect against unfavorable disadvantages of clinical liver cancer.
Publish Date 2021-10-13 12:57
Citation Cao L, Zhu YQ, Wu ZX, Wang GX, Cheng HW. Engineering nanotheranostic strategies for liver cancer. World J Gastrointest Oncol 2021; 13(10): 1213-1228
URL https://www.wjgnet.com/1948-5204/full/v13/i10/1213.htm
DOI https://dx.doi.org/10.4251/wjgo.v13.i10.1213
Full Article (PDF) WJGO-13-1213.pdf
Full Article (Word) WJGO-13-1213.docx
Manuscript File 66172-Review-FilipodiaCL.docx
Answering Reviewers 66172-Answering reviewers.pdf
Audio Core Tip 66172-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 66172-Conflict-of-interest statement.pdf
Copyright License Agreement 66172-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 66172-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 66172-Language certificate.pdf
Supplementary Material 66172-Copyright permission.pdf
Peer-review Report 66172-Peer-review(s).pdf
Scientific Misconduct Check 66172-Scientific misconduct check.pdf
Scientific Editor Work List 66172-Scientific editor work list.pdf